CAN.AX

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Drug Manufacturers - Specialty & Generic

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
CAN.AXCann Group Limited	$0.01	-0.00%	$4M	—
ADR.AXAdherium Limited	$0.09	+0.00%	$2M	—
BGT.AXBio-Gene Technology Limited	$0.02	+0.00%	$5M	—
BIT.AXBiotron Limited	$0.00	+0.00%	$3M	—
ECS.AXECS Botanics Holdings Ltd	$0.01	+0.00%	$8M	—
HIQ.AXHITIQ Limited	$0.00	-11.11%	$4M	—
ICR.AXIntelicare Holdings Limited	$0.02	+9.52%	$11M	—

Source: Financial Modeling Prep · peers by sector/industry

Cann Group Limited

Cann Group Limited, established in Port Melbourne, Australia, in 2014, specializes in the comprehensive lifecycle of medicinal cannabis. This includes genetic development, cultivation, manufacturing, clinical assessment, and the distribution of therapeutic cannabis products. The company supplies these products for use within Australia and also exports them to international markets, operating under specific licenses that permit research and the cultivation of cannabis for human medicinal and scientific purposes.

www.canngrouplimited.com

Employees: 40
IPO / List date: May 5, 2017
HQ: AU

Held by traders on TradeandTell

No one on the platform currently holds CAN.AX.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in CAN.AX as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded CAN.AX yet.